The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
siRNA-based approaches in cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hairpin RNAs and Retrotransposon LTRs Effect RNAi and Chromatin-Based Gene Silencing
Schramke, V., & Allshire, R. (2003) · Science · doi:10.1126/science.1086870 · Cited by 307
RetractedPotent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,538
An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells
Hammond, S. M., Bernstein, E., Beach, D., & Hannon, G. J. (2000) · Nature · doi:10.1038/35005107 · Cited by 3,003
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
Effective targeted gene ‘knockdown’ in zebrafish
Nasevicius, A., & Ekker, S. C. (2000) · Nature Genetics · doi:10.1038/79951 · Cited by 2,483
Expression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370
Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0637 · Cited by 2,354
Regulation of Heterochromatic Silencing and Histone H3 Lysine-9 Methylation by RNAi
Volpe, T. A., Kidner, C., Hall, I. M., Teng, G., Grewal, S. I. S., & Martienssen, R. A. (2002) · Science · doi:10.1126/science.1074973 · Cited by 2,055
Zamecnik, P. C., & Stephenson, M. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.280 · Cited by 1,792
Reduced accumulation of specific microRNAs in colorectal neoplasia.
Michael, M., Connor, S. M. O., Pellekaan, N. V. H., Young, G. P., & James, R. J. (2003) · PubMed · Cited by 1,775
Rubinson, D. A., Dillon, C. P., Kwiatkowski, A. V., Sievers, C., Yang, L., Kopinja, J., Rooney, D. L., Zhang, M., Ihrig, M. M., McManus, M. T., et al. (2003) · Nature Genetics · doi:10.1038/ng1117 · Cited by 1,501
Lai, E. C. (2002) · Nature Genetics · doi:10.1038/ng865 · Cited by 1,473
Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate
Elbashir, S. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6877 · Cited by 1,449
Activation of the interferon system by short-interfering RNAs
Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H., & Williams, B. R. G. (2003) · Nature Cell Biology · doi:10.1038/ncb1038 · Cited by 1,400
Molecular Determinants for the Tissue Specificity of SERMs
Shang, Y., & Brown, M. (2002) · Science · doi:10.1126/science.1068537 · Cited by 1,146
Morpholino Antisense Oligomers: Design, Preparation, and Properties
SUMMERTON, J., & WELLER, D. (1997) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1997.7.187 · Cited by 1,116
RNA interference targeting Fas protects mice from fulminant hepatitis
Song, E., Lee, S.-K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P., & Lieberman, J. (2003) · Nature Medicine · doi:10.1038/nm828 · Cited by 1,110
Napoli, C., Lemieux, C., & Jorgensen, R. (1990) · The Plant Cell · doi:10.2307/3869076 · Cited by 1,101
Unlocking the potential of the human genome with RNA interference
Hannon, G. J., & Rossi, J. J. (2004) · Nature · doi:10.1038/nature02870 · Cited by 1,064
RNA interference in adult mice
McCaffrey, A. P., Meuse, L., Pham, T.-T. T., Conklin, D. S., Hannon, G. J., & Kay, M. A. (2002) · Nature · doi:10.1038/418038a · Cited by 1,059
Antisense technologies: Improvement through novel chemical modifications
Kurreck, J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03555.x · Cited by 1,006
Perspective: machines for RNAi
Tomari, Y., & Zamore, P. D. (2005) · Genes & Development · doi:10.1101/gad.1284105 · Cited by 948
Antisense oligonucleotides: basic concepts and mechanisms.
Dias, N., & Stein, C. A. (2002) · PubMed · Cited by 948
Stable suppression of tumorigenicity by virus-mediated RNA interference
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00122-8 · Cited by 886
Induction and suppression of RNA silencing: insights from viral infections
Voinnet, O. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1555 · Cited by 827
Effective expression of small interfering RNA in human cells
Paul, C. P., Good, P. D., Winer, I., & Engelke, D. R. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-505 · Cited by 820
Frank-Kamenetskii, M. D., & Mirkin, S. M. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000433 · Cited by 808
Specific regulation of gene expression by antisense, sense and antigene nucleic acids
Hélène, C., & Toulmé, J.-J. (1990) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(90)90031-v · Cited by 768
Transcription and Processing of Human microRNA Precursors
Cullen, B. R. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.12.002 · Cited by 759
LNA (Locked Nucleic Acid): High-Affinity Targeting of Complementary RNA and DNA
Vester, B., & Wengel, J. (2004) · Biochemistry · doi:10.1021/bi0485732 · Cited by 727
Miyagishi, M., & Taira, K. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-497 · Cited by 710
A resource for large-scale RNA-interference-based screens in mammals
Paddison, P. J., Silva, J. M., Conklin, D. S., Schlabach, M., Li, M., Aruleba, S., Balija, V., O'Shaughnessy, A., Gnoj, L., Scobie, K., et al. (2004) · Nature · doi:10.1038/nature02370 · Cited by 695
Scacheri, P. C., Rozenblatt-Rosen, O., Caplen, N. J., Wolfsberg, T. G., Umayam, L., Lee, J. C., Hughes, C. M., Shanmugam, K. S., Bhattacharjee, A., Meyerson, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308698100 · Cited by 613
Efficient delivery of siRNA for inhibition of gene expression in postnatal mice
Lewis, D. L., Hagstrom, J. E., Loomis, A. G., Wolff, J. A., & Herweijer, H. (2002) · Nature Genetics · doi:10.1038/ng944 · Cited by 546
High expression of precursor microRNA‐155/BIC RNA in children with Burkitt lymphoma
Metzler, M., Wilda, M., Busch, K., Viehmann, S., & Borkhardt, A. (2004) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10316 · Cited by 543
Structural gene identification and mapping by DNA-mRNA hybrid-arrested cell-free translation.
Paterson, B. M., Roberts, B. E., & Kuff, E. L. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.10.4370 · Cited by 536
RNA Interference in Mammalian Cells by Chemically-Modified RNA
Braasch, D. A., Jensen, S., Liu, Y., Kaur, K., Arar, K., White, M. A., & Corey, D. R. (2003) · Biochemistry · doi:10.1021/bi0343774 · Cited by 531
PERSENGIEV, S. P., ZHU, X., & GREEN, M. R. (2004) · RNA · doi:10.1261/rna5160904 · Cited by 530
Small RNAs Correspond to Centromere Heterochromatic Repeats
Reinhart, B. J., & Bartel, D. P. (2002) · Science · doi:10.1126/science.1077183 · Cited by 503
Gene Silencing by Systemic Delivery of Synthetic siRNAs in Adult Mice
Sørensen, D. R., Leirdal, M., & Sioud, M. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00181-5 · Cited by 464
Karikó, K., Bhuyan, P., Capodici, J., & Weissman, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6545 · Cited by 449
siRNA and miRNA: an insight into RISCs
Tang, G. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.12.007 · Cited by 449
Small RNAs with Imperfect Match to Endogenous mRNA Repress Translation
Saxena, S., Jónsson, Z. O., & Dutta, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307089200 · Cited by 436
Progress in antisense technology
Crooke, S. T. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104408 · Cited by 417
The developmental role of microRNA in plants
Kidner, C. A., & Martienssen, R. A. (2005) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2004.11.008 · Cited by 403
Noise amidst the silence: off-target effects of siRNAs?
Jackson, A. L., & Linsley, P. S. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.08.006 · Cited by 368
Adenovirus VA1 Noncoding RNA Can Inhibit Small Interfering RNA and MicroRNA Biogenesis
Lu, S., & Cullen, B. R. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12868-12876.2004 · Cited by 362
Post-transcriptional gene silencing across kingdoms
Cogoni, C., & Macino, G. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00134-9 · Cited by 354
Grimm, D., Kay, M. A., & Kleinschmidt, J. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00095-9 · Cited by 344
Local gene knockdown in the brain using viral-mediated RNA interference
Hommel, J. D., Sears, R. M., Georgescu, D., Simmons, D. L., & DiLeone, R. J. (2003) · Nature Medicine · doi:10.1038/nm964 · Cited by 334
Spankuch-Schmitt, B., Bereiter-Hahn, J., Kaufmann, M., & Strebhardt, K. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.24.1863 · Cited by 327
Burgess, T. L., Fisher, E. F., Ross, S. L., Bready, J. V., Qian, Y. X., Bayewitch, L. A., Cohen, A. M., Herrera, C. J., Hu, S. S., & Kramer, T. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.4051 · Cited by 320
Lentiviral-Mediated RNA Interference
Abbas-Terki, T., Blanco-Bose, W., Déglon, N., Pralong, W., & Aebischer, P. (2002) · Human Gene Therapy · doi:10.1089/104303402320987888 · Cited by 284
Butz, K., Ristriani, T., Hengstermann, A., Denk, C., Scheffner, M., & Hoppe-Seyler, F. (2003) · Oncogene · doi:10.1038/sj.onc.1206894 · Cited by 283
Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi)
Wilda, M., Fuchs, U., Wössmann, W., & Borkhardt, A. (2002) · Oncogene · doi:10.1038/sj.onc.1205653 · Cited by 276
Resistance of Morpholino Phosphorodiamidate Oligomers to Enzymatic Degradation
HUDZIAK, R. M., BAROFSKY, E., BAROFSKY, D. F., WELLER, D. L., HUANG, S.-B., & WELLER, D. D. (1996) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1996.6.267 · Cited by 275
The Role of Environmental Carcinogens, Viruses, and Genetic
Powers, A., & Carbone, M. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.4.4 · Cited by 274
Schrijver, E. D., Brusselmans, K., Heyns, W., Verhoeven, G., & Swinnen, J. V. (2003) · PubMed · Cited by 269
Reversal of Senescence in Mouse Fibroblasts through Lentiviral Suppression of p53
Dirac, A. M. G., & Bernards, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300023200 · Cited by 255
Novel Antisense and Peptide Nucleic Acid Strategies for Controlling Gene Expression
Braasch, D. A., & Corey, D. R. (2002) · Biochemistry · doi:10.1021/bi0122112 · Cited by 248
Antisense Oligonucleotides: Promise and Reality
Lebedeva, I., & Stein, C. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.403 · Cited by 236
Song, E., Lee, S.-K., Dykxhoorn, D. M., Novina, C., Zhang, D., Crawford, K., Cerny, J., Sharp, P. A., Lieberman, J., Manjunath, N., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7174-7181.2003 · Cited by 230
Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells
Konnikova, L., Kotecki, M., Kruger, M. M., & Cochran, B. H. (2003) · BMC Cancer · doi:10.1186/1471-2407-3-23 · Cited by 217
Cellular Uptake of Antisense Morpholino Oligomers Conjugated to Arginine-Rich Peptides
Moulton, H. M., Nelson, M. H., Hatlevig, S. A., Reddy, M. T., & Iversen, P. L. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034221g · Cited by 210
Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi)
Nieth, C., Priebsch, A., Stege, A., & Lage, H. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00523-4 · Cited by 200
Improvement through novel chemical modifications
Kurreck, J. (2003) · Cited by 179
Uchida, H., Tanaka, T., Sasaki, K., Kato, K., Dehari, H., Ito, Y., Kobune, M., Miyagishi, M., Taira, K., Tahara, H., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.006 · Cited by 175
Lacerra, G., Sierakowska, H., Carestia, C., Fucharoen, S., Summerton, J., Weller, D., & Kole, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9591 · Cited by 159
Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides
Krieg, A. Μ. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00147-5 · Cited by 154
Iversen, P. L., Arora, V., Acker, A., Mason, D. H., & Devi, G. R. (2003) · PubMed · Cited by 145
Self-citationAntisense and siRNA as agonists of Toll-like receptors
Agrawal, S., & Kandimalla, E. R. (2004) · Nature Biotechnology · doi:10.1038/nbt1042 · Cited by 144
Wohlbold, L., van der Kuip, H., Miething, C., Vornlocher, H., Knabbe, C., Duyster, J., & Aulitzky, W. E. (2003) · Blood · doi:10.1182/blood-2002-12-3899 · Cited by 142
Duxbury, M. S., Ito, H., Benoit, E. P., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.060 · Cited by 126
Sancéau, J., Truchet, S., & Bauvois, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304300200 · Cited by 123
Inhibition of Coagulation by a Phosphorothioate Oligonucleotide
Henry, S. P., Novotny, W. F., LEEDS, J., Auletta, C. S., & Kornbrust, D. J. (1997) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1997.7.503 · Cited by 122
Zhang, L., Yang, N., Mohamed-Hadley, A. A., Rubin, S. C., & Coukos, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00495-9 · Cited by 121
Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue
Cohen, C. D., Gröne, H., Gröne, E. F., Nelson, P. J., Schlöndorff, D., & Kretzler, M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00112.x · Cited by 114
Devi, G. R., Beer, T. M., Corless, C. L., Arora, V., Weller, D. L., & Iversen, P. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2091 · Cited by 111
Self-citationSynthetic Hammerhead Ribozymes as Therapeutic Tools to Control Disease Genes
Citti, L., & Rainaldi, G. (2005) · Current Gene Therapy · doi:10.2174/1566523052997541 · Cited by 99
London, C. A., Sekhon, H. S., Arora, V., Stein, D. A., Iversen, P. L., & Devi, G. R. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700642 · Cited by 95
Self-citationNagy, P., Arndt‐Jovin, D. J., & Jovin, T. M. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00050-2 · Cited by 94
Grzmil, M., Thelen, P., Hemmerlein, B., Schweyer, S., Voigt, S., Mury, D., & Burfeind, P. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63682-6 · Cited by 94
Adenoviral Vectors Expressing siRNAs for Discovery and Validation of Gene FunctionPreprint
Arts, G., Langemeijer, E., Tissingh, R., Ma, L., Pavliska, H., Dokic, K., Dooijes, R., Mešić, E., Clasen, R., Michiels, F., et al. (2003) · Genome Research · doi:10.1101/gr.1332603 · Cited by 92
Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
Orr, R. M. (2001) · PubMed · Cited by 88
Henry, S. P., Geary, R. S., Yu, R. Z., & Levin, A. A. (2001) · PubMed · Cited by 79
Arora, V., Knapp, D. C., Reddy, M. T., Weller, D. D., & Iversen, P. L. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10088 · Cited by 79
Arora, V., Devi, G. R., & Iversen, P. L. (2004) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201043376706 · Cited by 77
Self-citationInhibition of telomerase activity in human cancer cells by RNA interference.
Kosciolek, B. A., Kalantidis, K., Tabler, M., & Rowley, P. T. (2003) · PubMed · Cited by 76
siRNA agents inhibit oncogene expression and attenuate human tumor cell growth
Yin, J. Q., Gao, J., Shao, R., Tian, W., Wang, J., & Wan, Y. (2003) · Journal of Experimental Therapeutics and Oncology · doi:10.1046/j.1359-4117.2003.01092.x · Cited by 73
Specific gene inhibition by adenovirus-mediated expression of small interfering RNA
Zhao, L.-J., Jian, H., & Zhu, H. (2003) · Gene · doi:10.1016/s0378-1119(03)00750-9 · Cited by 72
Arora, V., Knapp, D. C., Smith, B. L., Statdfield, M., Stein, D. A., Reddy, M. T., Weller, D. D., & Iversen, P. L. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35371-6 · Cited by 71
Knapp, D. C., Mata, J. E., Reddy, M. T., Devi, G. R., & Iversen, P. L. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200301000-00006 · Cited by 67
Self-citationHudziak, R. M., Summerton, J. E., Weller, D. D., & Iversen, P. L. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.163 · Cited by 67
Peptide nucleic acids: versatile tools for gene therapy strategies
Dean, D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00087-9 · Cited by 61
Anti-Genes: siRNA, Ribozymes and Antisense
Scanlon, K. J. (2004) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201043376689 · Cited by 61
In Vivo Modulation of N- myc Expression by Continuous Perfusion with an Antisense Oligonucleotide
Whitesell, L. J., ROSOLEN, A., & NECKERS, L. M. (1991) · Antisense Research and Development · doi:10.1089/ard.1991.1.343 · Cited by 58
c-myc antisense oligonucleotide treatment ameliorates murine ARPKD
Ricker, J. L., Mata, J. E., Iversen, P. L., & Gattone, V. H. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.0610s1125.x · Cited by 57
Oncology studies using siRNA libraries: the dawn of RNAi-based genomics
Sachse, C., & Echeverri, C. J. (2004) · Oncogene · doi:10.1038/sj.onc.1208072 · Cited by 50
High-throughput gene silencing using cell arrays
Vanhecke, D., & Janitz, M. (2004) · Oncogene · doi:10.1038/sj.onc.1208027 · Cited by 50
Matzke, M. A., & Matzke, A. J. M. (2003) · Science · doi:10.1126/science.1089047 · Cited by 44
Devi, G. R., Oldenkamp, J. R., London, C. A., & Iversen, P. L. (2002) · The Prostate · doi:10.1002/pros.10151 · Cited by 38
Self-citationRetroviruses as tools to study the immune system
Lois, C., Refaeli, Y., Qin, F. X.-F., & Parijs, L. V. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00247-8 · Cited by 35
Arora, V., Cate, M. L., Ghosh, C., & Iversen, P. L. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.7.757 · Cited by 31
Ko, Y., Devi, G. R., London, C. A., Kayas, A., Reddy, M. T., Iversen, P. L., Bubley, G. J., & Balk, S. P. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000134698.87862.e6 · Cited by 29
Self-citationIversen, P. L., Cornish, K. G., Iversen, L. J., Mata, J. E., & Bylund, D. B. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8771 · Cited by 29
Kipshidze, N. N., Keane, E., Stein, D. A., Chawla, P., Skrinska, V., Shankar, L. R., Khanna, A. K., KOMOROWSKI, R. A., Haudenschild, C. C., Iversen, P. L., et al. (2001) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.1277 · Cited by 27
IGF-I: from diagnostic to triple-helix gene therapy of solid tumors.
Trojan, L. A., Kopinski, P., Wei, M., Ly, A., Głogowska, A., Czarny, J., Shevelev, A., Przewłocki, R., Hénin, D., & Trojan, J. (2002) · Acta Biochimica Polonica · doi:10.18388/abp.2002_3757 · Cited by 19
Evidence of Enhanced Iron Excretion During Systemic Phosphorothioate Oligodeoxynucleotide Treatment
Mata, J. E., Bishop, M. R., Tarantolo, S., Angle, C. R., Swanson, S. A., & Iversen, P. L. (2000) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-100100947 · Cited by 16
Prostate cancer: status of current treatments and emerging antisense-based therapies.
Devi, G. R. (2002) · PubMed · Cited by 16
Self-citationUse of multiply deleted adenovirus vectors to probe adenovirus vector performance and toxicities.
Amalfitano, A. (2003) · PubMed · Cited by 8
Cited by
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Lim, E.-K., Kim, T., Paik, S., Haam, S., Huh, Y.-M., & Lee, K. (2015) · Chemical Reviews · doi:10.1021/cr300213b · Cited by 1,233
Yao, J., Yang, M., & Duan, Y. (2014) · Chemical Reviews · doi:10.1021/cr200359p · Cited by 944
Farazi, T. A., Hoell, J. I., Morozov, P., & Tuschl, T. (2013) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-007-5590-1_1 · Cited by 693
Lipids and Lipid Derivatives for RNA Delivery
Zhang, Y., Sun, C., Wang, C., Jankovic, K. E., & Dong, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00244 · Cited by 626
Applications and potential toxicity of magnetic iron oxide nanoparticles
Liu, G., Gao, J., Ai, H., & Chen, X. (2013) · Small · doi:10.1002/smll.201201531 · Cited by 570
Metadata
- Authors
- Devi, G. R.
- Venue
- Cancer Gene Therapy
- Published
- 2006-01-20
- Volume
- 13
- Issue
- 9
- Pages
- 819-829
- ISSN
- 0929-1903 (ISSN-L)
- 1476-5500
- OpenAlex
- W2058627189
- Cited by
- 353
- References
- 115
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.